Editorial: Novel immunotherapies to treat gastrointestinal solid tumor cancers

Front Oncol. 2022 Oct 24:12:1043615. doi: 10.3389/fonc.2022.1043615. eCollection 2022.

Authors

Sripathi M Sureban¹, Vita Golubovskaya²

Affiliations

¹ Department of Internal Medicine, The University of Oklahoma Health Sciences, Oklahoma City, OK, United States.
² Promab Biotechnologies, Richmond, CA, United States.

No abstract available

Keywords: PD-1 - PD-L1 axis; clinical trials; gastrointestinal cancer (GI cancer); immunotherapies and vaccines; solid tumors.

Publication types

Editorial